KIIT-TBI Ecosystem with the support of
BIOTECHNOLOGY INDUSTRY RESEARCH ASSISTANCE COUNCIL (BIRAC)
About: Early Translation Accelerator (ETA)
Early Translation Accelerator (ETA), focus on catalyzing transformation of young academic discoveries (publications/patents) with possible commercially viable ventures and technologies. The aim of ETA is to add a translational component to establish proof-of-concept/ Validation and to attract the industry to take these validated technologies further in terms of development. KIIT-TBI as the BIRAC ETA center is responsible to facilitate collaboration with academic investigators, industry and to leverage international translation ecosystems.
Objectives: Early Translation Accelerator
◉Mining & Assessment of Technologies being developed at various universities
◉ Identifying at least 10 potential early-stage scientific discoveries which has at least reached TRL 5
◉ Building linkages between innovators and industry leaders for translation and further validation of research
◉ Scouting for Industrial partners and conceptualize the Translational project components
◉ Effective transfer of product prototype generated from ETA by successful licensing to industries or companies and filing of IP
Duration: Early Translation Accelerator
18 months
Eligibility: Early Translation Accelerator
◉Innovators and research scientists. clinicians from Universities and Academic, R&D institutions, and medical institutes in India
◉An innovative idea in the Healthcare sector focusing on Medical Devices and Diagnostics.
◉With commercial potential and ready for transferring the technology
◉The Technology has to be equal to or more than TRL 5 ( Please see the BIRAC TRL guidelines
Funding: Early Translation Accelerator
Funding up to INR 200 Lakhs/ Project
workflow: Early Translation Accelerator
Screening, selection, and onboarding of lab-validated innovations with TRL level 5 from academic Institutions.
Making the technology Industry ready and Building linkages between innovators and industry leaders for translation and further research validation.
Technology transfer for commercialization by industry partners.